User menu

JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.

Bibliographic reference Harrison, Claire ; Kiladjian, Jean-Jacques ; Al-Ali, Haifa Kathrin ; Gisslinger, Heinz ; Waltzman, Roger ; et. al. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.. In: New England Journal of Medicine, Vol. 366, no. 9, p. 787-798 (2012)
Permanent URL http://hdl.handle.net/2078/121681